| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Jody D Berry | |
| P2860 | cites work | Rabbit monoclonal antibodies: generating a fusion partner to produce rabbit-rabbit hybridomas | Q24562737 |
| Recombinant human Fab fragments neutralize human type 1 immunodeficiency virus in vitro | Q24563642 | ||
| In vitro selection and evolution of functional proteins by using ribosome display | Q24643887 | ||
| Continuous cultures of fused cells secreting antibody of predefined specificity | Q26776979 | ||
| Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface | Q29616401 | ||
| Antibody libraries in drug and target discovery. | Q30651035 | ||
| The immune diversity in a test tube--non-immunised antibody libraries and functional variability in defined protein scaffolds | Q30692616 | ||
| Isolation of single-chain antibody fragments against Venezuelan equine encephalomyelitis virus from two different immune sources | Q30725087 | ||
| Recombinant single-chain variable fragment antibodies directed against Clostridium difficile toxin B produced by use of an optimized phage display system | Q30782773 | ||
| Four chimpanzee monoclonal antibodies isolated by phage display neutralize hepatitis a virus | Q30823994 | ||
| Construction of murine phage antibody library and selection of ricin-specific single-chain antibodies | Q30833200 | ||
| Phage display of recombinant antibodies toward Burkholderia pseudomallei exotoxin | Q30843884 | ||
| Functional human monoclonal antibodies of all isotypes constructed from phage display library-derived single-chain Fv antibody fragments | Q30872736 | ||
| Antibody engineering at the millennium | Q30887166 | ||
| Antibody arrays for high-throughput screening of antibody-antigen interactions | Q30918339 | ||
| Isolation and expression of recombinant antibody fragments to the biological warfare pathogen Brucella melitensis. | Q30927283 | ||
| Human monoclonal Fab fragments derived from a combinatorial library bind to respiratory syncytial virus F glycoprotein and neutralize infectivity | Q30946151 | ||
| Rabbit immune repertoires as sources for therapeutic monoclonal antibodies: the impact of kappa allotype-correlated variation in cysteine content on antibody libraries selected by phage display | Q31121743 | ||
| Generation of native bovine mAbs by phage display | Q31932066 | ||
| A phage display approach for rapid antibody humanization: designed combinatorial V gene libraries. | Q32052178 | ||
| Relationship between three different B cell types and the specific efficiency of hybridoma formation | Q68972713 | ||
| A Mab to a unique cerebellar neuron generated by immunosuppression and rapid immunization | Q69092953 | ||
| Production of an ovine monoclonal antibody to testosterone by an interspecies fusion | Q69446233 | ||
| Preparation of a bovine monoclonal antibody to testosterone by interspecies fusion | Q69457152 | ||
| A modified method to induce immune polyclonal ascites fluid in BALB/c mice using Sp2/0-Ag14 cells | Q70018760 | ||
| Regulation of IgM and IgD synthesis in B lymphocytes. I. Changes in biosynthesis of mRNA for mu- and delta-chains | Q70463313 | ||
| The identification of monoclonal class switch variants by sib selection and an ELISA assay | Q70507327 | ||
| Production of monoclonal antibodies by genetic immunization | Q72045278 | ||
| Effect of cationization on anti-hapten antibody responses in sheep and mice | Q72787955 | ||
| Development of functional human monoclonal single-chain variable fragment antibody against HIV-1 from human cervical B cells | Q73585960 | ||
| Analyzing antibody specificity with whole proteome microarrays | Q79275455 | ||
| . . . and such are little lymphocytes made of | Q95805708 | ||
| Simian immunodeficiency virus (SIV) envelope-specific Fabs with high-level homologous neutralizing activity: recovery from a long-term-nonprogressor SIV-infected macaque | Q32157141 | ||
| Antibody-ribosome-mRNA (ARM) complexes as efficient selection particles for in vitro display and evolution of antibody combining sites | Q32182653 | ||
| Identification by phage display and characterization of two neutralizing chimpanzee monoclonal antibodies to the hepatitis E virus capsid protein | Q33180421 | ||
| Searching for Peptide Ligands with an Epitope Library | Q33256793 | ||
| Influenza virus hemagglutinin-specific antibodies isolated from a combinatorial expression library are closely related to the immune response of the donor | Q33257211 | ||
| Making antibody fragments using phage display libraries | Q33392386 | ||
| Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains | Q33392787 | ||
| Peptides on phage: a vast library of peptides for identifying ligands | Q33752327 | ||
| Characterization of a macaque recombinant monoclonal antibody that binds to a CD4-induced epitope and neutralizes simian immunodeficiency virus | Q33809225 | ||
| Random peptide libraries: a source of specific protein binding molecules | Q33853651 | ||
| Mouse/human chimeric monoclonal antibody in man: kinetics and immune response | Q33867651 | ||
| Veterinary sources of nonrodent monoclonal antibodies: interspecific and intraspecific hybridomas | Q34010553 | ||
| Phage antibodies: filamentous phage displaying antibody variable domains | Q34031345 | ||
| Electron microscopy for rapid diagnosis of infectious agents in emergent situations | Q34219176 | ||
| Evolution of immunoglobulin genes: VH families in the amphibian Xenopus | Q34313184 | ||
| Human antibodies as next generation therapeutics | Q34318042 | ||
| Production of human monoclonal and polyclonal antibodies in TransChromo animals | Q34634571 | ||
| Characterization of human class-switched polymeric (immunoglobulin M [IgM] and IgA) anti-human immunodeficiency virus type 1 antibodies 2F5 and 2G12. | Q34781840 | ||
| Mouse variable-region gene families: complexity, polymorphism and use in non-autoimmune responses | Q35499819 | ||
| Antibody recognition of a neutralization epitope on the major outer membrane protein of Chlamydia trachomatis | Q35778506 | ||
| Antibody-selectable filamentous fd phage vectors: affinity purification of target genes | Q36434701 | ||
| Clinical laboratory applications of monoclonal antibodies | Q36633211 | ||
| Neutralizing recombinant human antibodies to a conformational V2- and CD4-binding site-sensitive epitope of HIV-1 gp120 isolated by using an epitope-masking procedure. | Q36677139 | ||
| Neutralizing murine monoclonal antibodies to human IL-5 isolated from hybridomas and a filamentous phage Fab display library | Q36704541 | ||
| Human antibodies from combinatorial libraries. | Q36717602 | ||
| Isolation of tumor cell-specific single-chain Fv from immunized mice using phage-antibody libraries and the re-construction of whole antibodies from these antibody fragments | Q36746452 | ||
| Molecular profile of an antibody response to HIV-1 as probed by combinatorial libraries | Q36781196 | ||
| Construction of a combinatorial IgE library from an allergic patient. Isolation and characterization of human IgE Fabs with specificity for the major timothy grass pollen allergen, Phl p 5. | Q36799171 | ||
| The sheep Ig variable region repertoire consists of a single VH family. | Q36805989 | ||
| Reliable cloning of functional antibody variable domains from hybridomas and spleen cell repertoires employing a reengineered phage display system | Q36846512 | ||
| Evaluation of different lymphoid tissue sources for the construction of human immunoglobulin gene libraries | Q36889578 | ||
| Human monoclonal Fab fragments specific for viral antigens from combinatorial IgA libraries | Q36891703 | ||
| A novel strategy for generating monoclonal antibodies from single, isolated lymphocytes producing antibodies of defined specificities | Q37444686 | ||
| Regulation of tryptophan synthase gene expression in Chlamydia trachomatis | Q37868735 | ||
| DNA vaccination with the major outer-membrane protein gene induces acquired immunity to Chlamydia trachomatis (mouse pneumonitis) infection | Q37882100 | ||
| The dynamic nature of the antibody repertoire | Q39545231 | ||
| Distinct mechanisms of neutralization by monoclonal antibodies specific for sites in the N-terminal or C-terminal domain of murine leukemia virus SU | Q39736690 | ||
| Production of monoclonal antibodies: strategy and tactics | Q40300743 | ||
| The evaluation of limiting dilution assays | Q40328249 | ||
| Production of fully human antibodies by transgenic mice | Q40425294 | ||
| Developments in international standardization | Q40784793 | ||
| Monoclonal antibodies, against O1 serotype foot-and-mouth disease virus, from a natural bovine host, recognize similar antigenic features to those defined by the mouse | Q41021945 | ||
| Neutralization antigenic sites on type Asia-1 foot-and-mouth disease virus defined by monoclonal antibody-resistant variants | Q41060791 | ||
| Characteristics of human antibody repertoires following active immune responses in vivo | Q41076845 | ||
| Refocusing neutralizing antibody response by targeted dampening of an immunodominant epitope. | Q41103077 | ||
| Synthetic peptides corresponding to the F protein of RSV stimulate murine B and T cells but fail to confer protection | Q41138576 | ||
| Tolerization of adult mice to immunodominant proteins before monoclonal antibody production | Q41607247 | ||
| Identification of two neutralizing and 8 non-neutralizing epitopes on simian immunodeficiency virus envelope using monoclonal antibodies | Q41621929 | ||
| Epitope masking and immunodominance--complications in the selection of monoclonal antibodies against HCG. | Q41993922 | ||
| Rapid cloning of any rearranged mouse immunoglobulin variable genes | Q42799553 | ||
| Mouse Monoclonal Antibodies to Human Immunodeficiency Virus Glycoprotein 120 Generated by Repeated Immunization with Glycoprotein 120 from a Single Isolate, or by Sequential Immunization with Glycoprotein 120 from Three Isolates | Q42803971 | ||
| How many specific B cells are needed to protect against a virus? | Q43547853 | ||
| Enhancement of alpha -helicity in the HIV-1 inhibitory peptide DP178 leads to an increased affinity for human monoclonal antibody 2F5 but does not elicit neutralizing responses in vitro. Implications for vaccine design | Q44141083 | ||
| A simple, single-step technique for selecting and cloning hybridomas for the production of monoclonal antibodies | Q44837712 | ||
| Immunoassay of infectious agents | Q45108849 | ||
| Immunoprophylaxis in fish by injection of mouse antibody genes. | Q45135263 | ||
| Rapid correlation between field isolates and vaccine strains of foot-and-mouth disease virus | Q45840705 | ||
| Development and characterisation of neutralising monoclonal antibody to the SARS-coronavirus | Q47245952 | ||
| Bovine IgG repertoire is dominated by a single diversified VH gene family | Q48044200 | ||
| PCR strategies for isolation of the 5' end of an immunoglobulin-encoding bovine cDNA. | Q48068171 | ||
| Rapid cloning of rearranged immunoglobulin genes from human hybridoma cells using mixed primers and the polymerase chain reaction | Q48297070 | ||
| Cloning immunoglobulin variable domains for expression by the polymerase chain reaction. 1989 | Q49011050 | ||
| Rapid Monoclonal Antibody Generation Via Dendritic Cell TargetingIn Vivo | Q51837773 | ||
| Acute and long-term effects of booster immunisation on frequencies of antigen-specific memory B-lymphocytes. | Q52016697 | ||
| Dynamics of B cell repertoire formation: normal patterns of clonal turnover are altered by ligand interaction. | Q52285282 | ||
| Potential of primate monoclonal antibodies to substitute for human antibodies: nucleotide sequence of chimpanzee Fab fragments. | Q52848309 | ||
| Antigenic competition in the immune response against protein mixtures: strain-specific non-immunogenicity of Escherichia coli antigens. | Q54751880 | ||
| Neutralizing cross-reactive and non-neutralizing monoclonal antibodies to HIV-1 gp120. | Q55241949 | ||
| Original and artificial antibodies | Q59028044 | ||
| Effect of the elapsed time after the final antigen boost on the specificity of monoclonal antibodies produced by B cell hybridomas | Q68096445 | ||
| Subtractive immunization techniques for the production of monoclonal antibodies to rare antigens | Q68232657 | ||
| A bovine monoclonal antibody to oestrone/oestradiol prepared by a (murine x bovine) xbovine interspecies fusion | Q68383926 | ||
| Specific amplification of rearranged immunoglobulin variable region genes from mouse hybridoma cells | Q68631230 | ||
| The use of tolerization in the production of monoclonal antibodies against minor antigenic determinants | Q68967573 | ||
| P433 | issue | 2 | |
| P921 | main subject | monoclonal antibody | Q422248 |
| animal disease | Q9190427 | ||
| antibody | Q79460 | ||
| emerging pathogen | Q108429945 | ||
| P304 | page(s) | 193-211 | |
| P577 | publication date | 2005-09-01 | |
| P1433 | published in | The Veterinary Journal | Q15752615 |
| P1476 | title | Rational monoclonal antibody development to emerging pathogens, biothreat agents and agents of foreign animal disease: The antigen scale | |
| P478 | volume | 170 |
| Q51579727 | A protein chip approach for high-throughput antigen identification and characterization. |
| Q39507829 | Anthrax spore detection by a luminex assay based on monoclonal antibodies that recognize anthrose-containing oligosaccharides |
| Q37862783 | Antibodies in infectious diseases: polyclonals, monoclonals and niche biotechnology |
| Q35754894 | Epitope characterization of sero-specific monoclonal antibody to Clostridium botulinum neurotoxin type A |
| Q37116508 | Francisella tularensis infection-derived monoclonal antibodies provide detection, protection, and therapy |
| Q34103619 | Llama-derived single domain antibodies specific for Abrus agglutinin |
| Q33688229 | Neutralizing epitopes of the SARS-CoV S-protein cluster independent of repertoire, antigen structure or mAb technology |
| Q37929687 | Neutralizing human monoclonal antibodies to severe acute respiratory syndrome coronavirus: target, mechanism of action, and therapeutic potential |
| Q41907832 | Peptide specific monoclonal antibodies of Leptospiral LigA for acute diagnosis of leptospirosis |
| Q84070162 | Production and immunoanalytical application of 32 monoclonal antibodies against metacestode somatic antigens of Echinococcus multilocularis |
| Q81132528 | When will rAbs replace mAbs in labs? |
Search more.